Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques
A Randomized Double-Blind Placebo-Controlled Crab Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques in NTU Campus
1 other identifier
interventional
80
1 country
1
Brief Summary
Purpose of this study is to determine whether NAET procedures are effective in the treatment of crab or shrimp allergy. Hypothesis: experimental group will show a significant improvement over the control group in allergic symptom, serum crab- or shrimp-specific IgE and skin test for crab or shrimp extract.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 2, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedFirst Posted
Study publicly available on registry
August 5, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedAugust 5, 2014
August 1, 2014
2.1 years
January 2, 2013
August 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in allergic symptoms at 6 months
Symptoms when exposed to crab or shrimp which include symptoms of skin, eye, respiratory tract, gastrointestinal tract, cardiovascular system and others. The participants give score subjectively from 0 to 10 according to the severity of the symptoms.
before NAET and 6 months after NAET
Secondary Outcomes (2)
Serum crab- or shrimp-specific IgE
before NAET, 1 month, 3 months and 6 months after NAET
Skin test
before NAET, 1 month and 6 months after NAET
Study Arms (2)
Crab or shrimp
EXPERIMENTALIntervention: treated with crab and shrimp energy signature vial using NAET
Placebo
PLACEBO COMPARATORTreated with water vial
Interventions
NAET with acupressure and/or chiropractic procedures with the participant holding crab and shrimp energy signature vial
Eligibility Criteria
You may qualify if:
- Older or equal to 20 years old
- History of allergic to crab or shrimp
- Positive serum crab- or shrimp-specific IgE
You may not qualify if:
- History of anaphylactic shock
- On medication of anti-histamine or steroid
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cha Ze Lee, MD, PhD
National Taiwan University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2013
First Posted
August 5, 2014
Study Start
June 1, 2012
Primary Completion
July 1, 2014
Study Completion
December 1, 2014
Last Updated
August 5, 2014
Record last verified: 2014-08